CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- SC 13G/A Stake Amended Statement of Ownership
- 5 Insider Annual Insider Trading Report
- SC 13G/A Stake Amended Statement of Ownership
- 5 Insider Annual Insider Trading Report
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $71.16 ($562,161)
- 4 Open-market sale Chief Business Officer sold 6,944 shares at $69.91 ($485,424)
- 8-K Event Other events
- 4 Open-market sale EVP, Research & CSO sold 31,300 shares at $48.17 ($1,507,806)
- 4 Open-market sale EVP, Research & CSO sold 10,530 shares at $38.00 ($400,140)
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $29.36 ($111,696)
- 8-K Event Material agreement
- 4 Open-market sale Chief Business Officer sold 6,945 shares at $26.32 ($182,795)
- 8-K Event Material agreement
- 4 Option exercise EVP, Research & CSO acquired 9,500 shares (option exercise)
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $31.19 ($118,683)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $31.27 ($118,966)
Page 31 of 41 · 806 filings